• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种新型α1-抗胰蛋白酶缺失变体(Q0开罗)的鉴定。

Identification of a novel alpha1-antitrypsin null variant (Q0Cairo).

作者信息

Zorzetto Michele, Ferrarotti Ilaria, Campo Ilaria, Balestrino Antonella, Nava Stefano, Gorrini Marina, Scabini Roberta, Mazzola Paola, Luisetti Maurizio

机构信息

Clinica Malattie Apparato Respiratorio, IRCCS Policlinico S. Matteo, Pavia 27100, Italy.

出版信息

Diagn Mol Pathol. 2005 Jun;14(2):121-4. doi: 10.1097/01.pas.0000155023.74859.d6.

DOI:10.1097/01.pas.0000155023.74859.d6
PMID:15905697
Abstract

Alpha1-antitrypsin deficiency (AATD) is a common hereditary disorder associated with high risk of developing pulmonary emphysema early in life and, to a lesser extent, chronic liver disease and cirrhosis. Among Northern Europeans and Northern Americans, more than 95% of individuals with emphysema associated with AATD carry the most frequent AAT deficient gene variants, PIZ and PIS. Rare AAT deficient variants account for 2-4% of AATD individuals. We extend the sequence data on AAT by characterizing a novel Null allele detected in 3 subjects: a carrier belonging to an Italian/Egyptian family and 2 members of a family originating from Southern Italy. The mutation raised on a M1 (Ala213) base allele and it is characterized by an A-->T transversion at exon III, nt 218, codon 259 (AAA-->TAA) (GeneBank accession number AY 256958). The transversion results in a premature stop codon (Lys259AAA-->Stop259TAA). The proposed nomenclature of Q0cairo is from the birthplace of the father of first recognized subject. Serum levels and isoelectric focusing of AAT were consistent with the presence of the Null variant.

摘要

α1-抗胰蛋白酶缺乏症(AATD)是一种常见的遗传性疾病,与早年发生肺气肿的高风险相关,在较小程度上还与慢性肝病和肝硬化有关。在北欧人和北美人中,超过95%患有与AATD相关的肺气肿的个体携带最常见的AAT缺陷基因变体PIZ和PIS。罕见的AAT缺陷变体占AATD个体的2 - 4%。我们通过对在3名受试者中检测到的一种新型无效等位基因进行特征分析,扩展了AAT的序列数据:一名属于意大利/埃及家庭的携带者以及一名来自意大利南部家庭的2名成员。该突变发生在一个M1(Ala213)碱基等位基因上,其特征是外显子III第218位核苷酸、密码子259(AAA→TAA)处发生A→T颠换(基因库登录号AY 256958)。这种颠换导致一个提前的终止密码子(Lys259AAA→Stop259TAA)。提议的命名Q0cairo来自首个被确认受试者父亲的出生地。AAT的血清水平和等电聚焦与无效变体的存在一致。

相似文献

1
Identification of a novel alpha1-antitrypsin null variant (Q0Cairo).一种新型α1-抗胰蛋白酶缺失变体(Q0开罗)的鉴定。
Diagn Mol Pathol. 2005 Jun;14(2):121-4. doi: 10.1097/01.pas.0000155023.74859.d6.
2
New -Acting Variants in PI*S Background Produce Null Phenotypes Causing Alpha-1 Antitrypsin Deficiency.新型 PI*S 背景下的变异导致产生无效表型,引起α-1 抗胰蛋白酶缺乏症。
Am J Respir Cell Mol Biol. 2020 Oct;63(4):444-451. doi: 10.1165/rcmb.2020-0021OC.
3
Alpha-1-antitrypsin deficiency associated with the Mattawa variant.与 Mattawa 变异体相关的α-1-抗胰蛋白酶缺乏症。
Arch Bronconeumol. 2013 Dec;49(12):548-50. doi: 10.1016/j.arbres.2013.05.004. Epub 2013 Oct 31.
4
Alpha-1-antitrypsin (SERPINA1) mutation spectrum: Three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal.α-1-抗胰蛋白酶(SERPINA1)突变谱:在葡萄牙鉴定出的三种新变体及罕见缺陷等位基因的单倍型特征
Respir Med. 2016 Jul;116:8-18. doi: 10.1016/j.rmed.2016.05.002. Epub 2016 May 3.
5
Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.利用蛋白质建模技术评估疑似患有α1-抗胰蛋白酶缺乏症患者的 SERPINA1 罕见变异体的致病性。
BMC Med Genet. 2019 Jul 15;20(1):125. doi: 10.1186/s12881-019-0852-5.
6
Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.模拟杂合子的细胞模型中α-1-抗胰蛋白酶突变体的杂聚合。
Hum Mol Genet. 2018 May 15;27(10):1785-1793. doi: 10.1093/hmg/ddy090.
7
Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization.三种新的α1-抗胰蛋白酶缺乏变体有助于定义调节构象变化和聚合的 C 末端区域。
PLoS One. 2012;7(6):e38405. doi: 10.1371/journal.pone.0038405. Epub 2012 Jun 18.
8
Identification and characterisation of eight novel SERPINA1 Null mutations.八个新型丝氨酸蛋白酶抑制剂A1(SERPINA1)无效突变的鉴定与特征分析
Orphanet J Rare Dis. 2014 Nov 26;9:172. doi: 10.1186/s13023-014-0172-y.
9
Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach.α-1抗胰蛋白酶缺乏症罕见缺陷变体Mmalton诊断算法的应用:一种新方法。
Int J Chron Obstruct Pulmon Dis. 2016 Oct 11;11:2535-2541. doi: 10.2147/COPD.S115940. eCollection 2016.
10
Alpha-1 antitrypsin Null mutations and severity of emphysema.α-1抗胰蛋白酶基因无效突变与肺气肿严重程度
Respir Med. 2008 Jun;102(6):876-84. doi: 10.1016/j.rmed.2008.01.009. Epub 2008 Mar 18.

引用本文的文献

1
Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review.罕见的α1 抗胰蛋白酶缺乏症变异体:系统文献回顾。
Orphanet J Rare Dis. 2024 Feb 22;19(1):82. doi: 10.1186/s13023-024-03069-1.
2
Novel SERPINA1 Alleles Identified through a Large Alpha-1 Antitrypsin Deficiency Screening Program and Review of Known Variants.通过大型α-1抗胰蛋白酶缺乏症筛查项目鉴定的新型SERPINA1等位基因及已知变异的综述。
Chronic Obstr Pulm Dis. 2023 Jan 25;10(1):7-21. doi: 10.15326/jcopdf.2022.0321.
3
Alpha1 antitrypsin deficiency due to an homozygous PI* Null Q0Cairo mutation: Early onset of pulmonary manifestations and variability of clinical expression.
由于纯合PI*无效Q0开罗突变导致的α1抗胰蛋白酶缺乏症:肺部表现的早发及临床表型的变异性
Respir Med Case Rep. 2018 Apr 10;24:58-62. doi: 10.1016/j.rmcr.2018.04.005. eCollection 2018.
4
The effect of α-antitrypsin deficiency combined with increased bacterial loads on chronic obstructive pulmonary disease pharmacotherapy: A prospective, parallel, controlled pilot study.α-抗胰蛋白酶缺乏症合并细菌负荷增加对慢性阻塞性肺疾病药物治疗的影响:一项前瞻性、平行、对照的试点研究。
J Adv Res. 2016 Nov;7(6):1019-1028. doi: 10.1016/j.jare.2016.05.002. Epub 2016 May 11.
5
Identification and characterisation of eight novel SERPINA1 Null mutations.八个新型丝氨酸蛋白酶抑制剂A1(SERPINA1)无效突变的鉴定与特征分析
Orphanet J Rare Dis. 2014 Nov 26;9:172. doi: 10.1186/s13023-014-0172-y.
6
Severe alpha-1 antitrypsin deficiency in composite heterozygotes inheriting a new splicing mutation QOMadrid.复合杂合子中严重的α-1抗胰蛋白酶缺乏症,其继承了一种新的剪接突变QOMadrid。
Respir Res. 2014 Oct 7;15(1):125. doi: 10.1186/s12931-014-0125-y.
7
Functional analysis of novel alpha-1 antitrypsin variants G320R and V321F.新型α-1抗胰蛋白酶变体G320R和V321F的功能分析
Mol Biol Rep. 2014 Sep;41(9):6133-41. doi: 10.1007/s11033-014-3492-z. Epub 2014 Jun 27.
8
A novel alpha1-antitrypsin null variant (PiQ0Milano ).一种新型的α1-抗胰蛋白酶缺失变体(PiQ0米兰型)
World J Hepatol. 2013 Aug 27;5(8):458-61. doi: 10.4254/wjh.v5.i8.458.
9
Why has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesis.为何证明α-1抗胰蛋白酶替代疗法的疗效如此困难?来自疾病发病机制研究的见解。
Drug Des Devel Ther. 2011;5:391-405. doi: 10.2147/DDDT.S14018. Epub 2011 Aug 17.
10
Screening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report.突尼斯阻塞性肺病患者α1抗胰蛋白酶缺乏症的筛查:一份可行性报告。
Orphanet J Rare Dis. 2009 Apr 15;4:12. doi: 10.1186/1750-1172-4-12.